4 completed. 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow isosorbide-hydralazine combination: new trials by email Literature Review of isosorbide-hydralazine combination trials Research Report on isosorbide-hydralazine combination
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DANHEART (H-HeFT and Met-HeFT) Hydralazine Isosorbide Dinitrate, Placebo Oral Tablet, Metformin Hydrochloride - Heart Failure, Diabetes | Phase 4 | Completed | Henrik Wiggers | 1100 | 2018-03-01 | 2026-06-11 |
| Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets BiDil XR, BiDil Immediate Release (IR) - Heart Failure | Phase 1 | Completed | Arbor Pharmaceuticals, Inc. | 12 | 2015-09-01 | 2016-11-08 |
| Genomic Response Analysis of Heart Failure Therapy in African Americans FDC I/H - Heart Failure | Completed | University of Pittsburgh | 225 | 2015-05-01 | 2023-04-20 | |
| African-American Heart Failure Trial BiDil - Congestive Heart Failure | Phase 4 | Completed | Nitromed | 1100 | 2001-05-01 | 2005-06-24 |
Heart Failure (4) · Diabetes Mellitus (1) · Insulin Resistance (1)
Arbor Pharmaceuticals, Inc. (1) · Henrik Wiggers (1) · Nitromed (1) · University of Pittsburgh (1)
United States (3) · Denmark (1)
Anne L. Taylor, M.D. (1) · Dennis McNamara, MD (1) · Finn Gustafsson, MD, PhD (1) · Gunnar Gislason, MD, PhD (1) · Henrik Wiggers, MD, PhD (1) · Steve D Caras, MD, PhD (1)
PMID 21742102, PMID 24970468, PMID 33039340
2015 (1)